Durvalumab Tolerability in Non–Small Cell Lung Cancer
1 Views
administrator
07/14/23
Discussing tolerability and adverse events of durvalumab. Understanding that early recognition and intervention is key to avoiding negative outcomes.
For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
-
Category
Show more
Facebook Comments
No comments found